University of Pennsylvania: New Cancer Immunotherapy Targeting Myeloid Cells Slows Tumor Growth
June 05, 2020
June 05, 2020
PHILADELPHIA, Pennsylvania, June 5 -- The University of Pennsylvania issued the following news:
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine and other institutions. Reporting in Nature Cancer, the researchers showed for the first time in human cells and a mouse model that inhibiting the c-Rel molecule in myeloid cells--as opposed to lymphoid cells that today's imm . . .
Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine and other institutions. Reporting in Nature Cancer, the researchers showed for the first time in human cells and a mouse model that inhibiting the c-Rel molecule in myeloid cells--as opposed to lymphoid cells that today's imm . . .